Morgan Stanley Maintains Equal-Weight on Exelixis, Raises Price Target to $53
Exelixis, Inc.
Exelixis, Inc. EXEL | 0.00 |
Morgan Stanley analyst Sean Laaman maintains Exelixis (NASDAQ:
EXEL) with a Equal-Weight and raises the price target from $50 to $53.